Molecular Partners Ag (MOLN) Operating Leases (2020 - 2025)

Molecular Partners Ag (MOLN) has reported Operating Leases for 6 consecutive years, with $4.6 million the latest figure, recorded in Q4 2025.

• Quarterly Operating Leases rose 63.42% year-over-year to $4.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.6 million (up 63.42% YoY) and the FY2025 annual result came in at $4.6 million, up 63.42% from the prior year.
• Operating Leases grew to $4.6 million in Q4 2025 per MOLN's latest filing, from $742852.5 in the prior quarter.
• Over the last five years, Operating Leases for MOLN reached as high as $6.5 million in Q4 2021 and fell as low as $742852.5 in Q2 2025.
• A 5-year average of $3.7 million and a median of $4.1 million in 2023 frame the typical range for Operating Leases.
• The largest YoY upside for Operating Leases was 63.42% in 2025 against a maximum downside of 63.43% in 2025.
• Year by year, Operating Leases stood at $6.5 million in 2021, then decreased by 23.13% to $5.0 million in 2022, then decreased by 18.22% to $4.1 million in 2023, then slumped by 32.24% to $2.8 million in 2024, then soared by 63.42% to $4.6 million in 2025.
• According to Business Quant data, Operating Leases over the past three periods registered $4.6 million, $742852.5, and $2.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.